Literature DB >> 29573407

Impaired muscle growth precedes development of increased stiffness of the triceps surae musculotendinous unit in children with cerebral palsy.

Maria Willerslev-Olsen1,2, Mai Choe Lund1,2, Jakob Lorentzen1,2, Lee Barber3, Mathilde Kofoed-Hansen2, Jens Bo Nielsen1,2.   

Abstract

AIM: If increased muscle stiffness and contractures in children with cerebral palsy (CP) are related to impaired muscle growth, reduced muscle growth should precede or coincide with increased muscle stiffness during development. Here, we compared the volume of the medial gastrocnemius muscle and the passive (non-neural) stiffness of the triceps surae musculotendinous unit in typically developing children and children with CP from birth until 4 years of age.
METHOD: Forty-one children with CP and 45 typically developing children were included. Freehand three-dimensional ultrasound was used to evaluate the volume of the medial gastrocnemius muscle. Biomechanical and electrophysiological measures were used to determine passive and reflex mediated stiffness of the triceps surae musculotendinous unit.
RESULTS: Medial gastrocnemius muscle volume increased with the same rate in typically developing and children with CP until 12 months of age, when a significant smaller rate of growth was observed in children with CP. Passive stiffness of the triceps surae musculotendinous unit showed a linear increase with age in typically developing children. Children with CP older than 27 months showed a significant increase in passive stiffness. Reflex mediated stiffness was only pathologically increased in four children with CP.
INTERPRETATION: The deviation of medial gastrocnemius muscle volume, earlier than musculotendinous unit stiffness, is consistent with the hypothesis. The data also point out that muscle atrophy and muscle stiffness already develops within the first 1 to 2 years. This emphasizes the necessity of early interventions to promote lower limb muscle growth in this population. WHAT THIS PAPER ADDS: Medial gastrocnemius muscle growth is reduced in children with cerebral palsy (CP) around 12 months after birth. Triceps surae musculotendinous unit stiffness is increased in children with CP around 27 months after birth. Reflex excitability is rarely increased in children with CP. Reduced muscle growth may be involved in the pathophysiology of contractures.
© 2018 Mac Keith Press.

Entities:  

Mesh:

Year:  2018        PMID: 29573407     DOI: 10.1111/dmcn.13729

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  15 in total

1.  Animal models of developmental motor disorders: parallels to human motor dysfunction in cerebral palsy.

Authors:  Clarissa F Cavarsan; Monica A Gorassini; Katharina A Quinlan
Journal:  J Neurophysiol       Date:  2019-08-14       Impact factor: 2.714

Review 2.  Over 25 Years of Pediatric Botulinum Toxin Treatments: What Have We Learned from Injection Techniques, Doses, Dilutions, and Recovery of Repeated Injections?

Authors:  Heli Sätilä
Journal:  Toxins (Basel)       Date:  2020-07-06       Impact factor: 4.546

3.  Exercise intervention protocol in children and young adults with cerebral palsy: the effects of strength, flexibility and gait training on physical performance, neuromuscular mechanisms and cardiometabolic risk factors (EXECP).

Authors:  Pedro Valadão; Harri Piitulainen; Eero A Haapala; Tiina Parviainen; Janne Avela; Taija Finni
Journal:  BMC Sports Sci Med Rehabil       Date:  2021-02-26

4.  Muscle Characteristics in Pediatric Hereditary Spastic Paraplegia vs. Bilateral Spastic Cerebral Palsy: An Exploratory Study.

Authors:  Nathalie De Beukelaer; Lynn Bar-On; Britta Hanssen; Nicky Peeters; Sandra Prinsen; Els Ortibus; Kaat Desloovere; Anja Van Campenhout
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 5.  Clinical Relevance of State-of-the-Art Analysis of Surface Electromyography in Cerebral Palsy.

Authors:  Germana Cappellini; Francesca Sylos-Labini; Carla Assenza; Laura Libernini; Daniela Morelli; Francesco Lacquaniti; Yury Ivanenko
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

6.  Gastrocnemius Medialis Muscle Geometry and Extensibility in Typically Developing Children and Children With Spastic Paresis Aged 6-13 Years.

Authors:  Guido Weide; Peter A Huijing; Lynn Bar-On; Lizeth Sloot; Annemieke I Buizer; Jules G Becher; Jaap Harlaar; Richard T Jaspers
Journal:  Front Physiol       Date:  2020-11-23       Impact factor: 4.566

7.  COpenhagen Neuroplastic TRaining Against Contractures in Toddlers (CONTRACT): protocol of an open-label randomised clinical trial with blinded assessment for prevention of contractures in infants with high risk of cerebral palsy.

Authors:  Maria Willerslev-Olsen; Jakob Lorentzen; Katrine Røhder; Anina Ritterband-Rosenbaum; Mikkel Justiniano; Andrea Guzzetta; Ane Vibeke Lando; Anne-Mette Bæk Jensen; Gorm Greisen; Sofie Ejlersen; Line Zacho Pedersen; Britta Andersen; Patricia Lipthay Behrend; Jens Bo Nielsen
Journal:  BMJ Open       Date:  2021-07-06       Impact factor: 2.692

Review 8.  Stretching Interventions in Children With Cerebral Palsy: Why Are They Ineffective in Improving Muscle Function and How Can We Better Their Outcome?

Authors:  Barbara M Kalkman; Lynn Bar-On; Thomas D O'Brien; Constantinos N Maganaris
Journal:  Front Physiol       Date:  2020-02-21       Impact factor: 4.566

9.  Musculoskeletal Pathology in Cerebral Palsy: A Classification System and Reliability Study.

Authors:  H Kerr Graham; Pam Thomason; Kate Willoughby; Tandy Hastings-Ison; Renee Van Stralen; Benan Dala-Ali; Peter Wong; Erich Rutz
Journal:  Children (Basel)       Date:  2021-03-23

10.  Muscle architecture and passive lengthening properties of the gastrocnemius medialis and Achilles tendon in children who idiopathically toe-walk.

Authors:  Carla Harkness-Armstrong; Constantinos Maganaris; Roger Walton; David M Wright; Alfie Bass; Vasilios Baltzopoulos; Thomas D O'Brien
Journal:  J Anat       Date:  2021-06-09       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.